A team from the Max Planck Research Group for Systems Immunology at the University of Würzburg has identified a previously ...

A team from the Max Planck Research Group for Systems Immunology at the University of Würzburg has identified a previously ...

A team from the Max Planck Research Group for Systems Immunology at the University of Würzburg has identified a previously unknown phase of the immune response. The results, published in Science, ...

A team from the Max Planck Research Group for Systems Immunology at the University of Würzburg has identified a previously unknown phase of the immune response. These new insights have significant ...

This study uncovers dynamic immune adaptations during pregnancy through single-cell RNA sequencing of peripheral blood ...

adaptive immune response recognizes and targets specific pathogens. "Classically, what distinguishes the innate immune response from the adaptive immune response is that it doesn't adapt ...

CD47-amyloid-β-CD74 signaling is a key driver of adaptive immunosuppression in sepsis, suppressing B cells and impairing ...

AC Immune Reports Further Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease Active ...

AC Immune (ACIU) announced additional interim safety and positive immunogenicity data from the Phase 2 VacSYn clinical trial evaluating ...

AC Immune Reports Further Positive ... further updates later in 2025.” VacSYn is an adaptive, placebo-controlled, and biomarker-based Phase 2 study in patients with early PD, consisting of ...